The fact that curcumin administration in patients with cancer, including lung cancer, is strongly associated with a decreased level of inflammatory factors (interleukin 6 (IL-6), interleukin 8 (IL-8), and tumour necrosis factor alpha (TNF-α)) implies its strong potential for metastasis suppression [119]. This evidence concerns the gene IL6 and lung cancer.